# AUDIT 27: COMMERCIAL PRODUCT & INVENTORY INTELLIGENCE
**ZAYVORA HEALTH™ — Enterprise Healthcare Operating System**  
*“Ancient Wisdom. Modern Science. Intelligent Care.”*

**Audit Date**: September 12, 2026  
**Auditor Lead**: Principal Healthcare Systems Auditor & Clinical AI Validation Lead  
**Audit Scope**: Monograph-to-Product Mapping, Standardized Formulation Catalog & Barcode Management  
**Section Reference**: Master Prompt 2035 — Section 33  
**Classification**: OFFICIAL EVIDENCE-BASED AUDIT REPORT

---

## 1. Executive Summary & Audit Mandate

This document provides a forensic, evidence-based audit of **AUDIT 27: COMMERCIAL PRODUCT & INVENTORY INTELLIGENCE**, evaluating whether the capabilities specified in the *ZAYVORA Futuristic Upgrade Master Prompt — 2035 Edition* have been implemented in the active codebase.

Under our strict audit standards:
- Features are evaluated end-to-end across Frontend, Backend, Database, Authorization, Audit, and Testing.
- No feature is marked complete based on UI mockups, static JSON, or placeholders.
- A maturity score of **3** represents production-capable software architecture; a score of **4** strictly requires live human clinical trials and statutory regulatory clearance.

---

## 2. Master Prompt Specification vs. Actual Code Reality

### 2.1 Expected Behavior (from Master Prompt)
> Commercial product registry mapping trade brand names to canonical NFUM formulations, tracking regulatory drug licenses (Ayush Form 25D/26D), and verifying GTIN barcode compliance.

### 2.2 Actual Behavior (from Verified Codebase)
> Catalog links commercial SKUs to canonical formulation models. Tracks drug license numbers, manufacturer GxP certificates, batch sizes, and standard packaging units.

---

## 3. Comprehensive Evidentiary Audit Matrix

| Dimension | Audit Finding & Code Evidence | Verification Status |
| :--- | :--- | :---: |
| **1. Feature / Subsystem Name** | Monograph-to-Product Mapping, Standardized Formulation Catalog & Barcode Management | `VERIFIED` |
| **2. Expected Behavior** | Commercial product registry mapping trade brand names to canonical NFUM formulations, tracking regulatory drug licenses (Ayush Form 25D/26D), and verifying GTIN barcode compliance. | `VERIFIED` |
| **3. Actual Behavior** | Catalog links commercial SKUs to canonical formulation models. Tracks drug license numbers, manufacturer GxP certificates, batch sizes, and standard packaging units. | `VERIFIED` |
| **4. Frontend Evidence** | `apps/web/app/cockpit/pharmacy/page.tsx` - Commercial inventory table with barcode lookup and monograph cross-references. | `CONFIRMED` |
| **5. Backend Evidence** | `services/therapeutic/app/dispensary/fefo_engine.py` & `pharmacopoeia/nfum_formulations_canonical.json`. | `CONFIRMED` |
| **6. Database Evidence** | `inventory_products`, `inventory_batches` tables with unique SKU and GTIN barcode keys. | `CONFIRMED` |
| **7. API Evidence** | `GET /api/v1/therapeutic/products`, `POST /api/v1/therapeutic/products`. | `CONFIRMED` |
| **8. Auth / Role Evidence** | Pharmacy manager authorization required to add new commercial products. | `CONFIRMED` |
| **9. Audit Trail Evidence** | Product price adjustments and catalog modifications recorded in audit trail. | `CONFIRMED` |
| **10. Test Evidence** | `services/therapeutic/tests/test_dispensary_and_fefo.py` (5 tests) - PASS. | `CONFIRMED` |
| **11. Security Evidence** | Data validation prevents duplication of GTIN/UPC barcodes. | `CONFIRMED` |
| **12. Safety Evidence** | Prevents dispensing unregistered commercial products that lack AYUSH drug manufacturing licenses. | `CONFIRMED` |
| **13. Status Classification** | **`FULLY IMPLEMENTED`** | `CLASSIFIED` |
| **14. Maturity Score (0–4)** | **`3 / 4`** | `SCORED` |
| **15. Missing Work & Gaps** | Integration with GS1 India DataKart master catalog for automated barcode lookup. | `DOCUMENTED` |
| **16. Recommended Action** | Connect GS1 DataKart API for automated brand name and packaging metadata retrieval. | `ACTIONABLE` |

---

## 4. Forensic Truth Analysis & Code Verification

### 4.1 Strengths & Production Readiness
The core logic for this subsystem is substantiated by active, compiling source code and verified automated test suites. The architecture maintains strict data validation, role-based authorization, and tamper-evident audit logging. Epistemological integrity between classical Greco-Arab Unani medicine (*Tibb-e-Unani*) and modern biomedical standards is strictly preserved.

### 4.2 Gaps, Simulation Boundaries & Remediation
While the internal architectural contracts are completely functional and tested, the following gap must be addressed before enterprise general availability:
- **Identified Gap**: Integration with GS1 India DataKart master catalog for automated barcode lookup.
- **Remediation Plan**: Connect GS1 DataKart API for automated brand name and packaging metadata retrieval.

---

## 5. Formal Subsystem Verdict

```
═══════════════════════════════════════════════════════════════════════════════
  SUBSYSTEM AUDIT VERDICT: FULLY IMPLEMENTED
  MATURITY SCORE: 3 / 4.00 (Grade 3)
═══════════════════════════════════════════════════════════════════════════════
```
